Inhalable drugs for systemic therapy.
نویسنده
چکیده
Although oral and injectable drug formulations still dominate the market, interest in pulmonary delivery has been rising steadily. Given patients' desire for an alternative to injections, and recent advances in aerosol science and pulmonary medicine, the potential for improved disease management outcomes by using aerosols for systemic drug delivery should lead the way for a shift to inhalables.
منابع مشابه
Antitubercular inhaled therapy: opportunities, progress and challenges.
Pulmonary tuberculosis remains the commonest form of this disease and the development of methods for delivering antitubercular drugs directly to the lungs via the respiratory route is a rational therapeutic goal. The obvious advantages of inhaled therapy include direct drug delivery to the diseased organ, targeting to alveolar macrophages harbouring the mycobacteria, reduced risk of systemic to...
متن کاملLiposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications
This is a critical review on research conducted in the field of pulmonary delivery of liposomes. Issues relating to the mechanism of nebulisation and liposome composition were appraised and correlated with literature reports of liposome formulations used in clinical trials to understand the role of liposome size and composition on therapeutic outcome. A major highlight was liposome inhalation f...
متن کاملIngredient-specific Particle Sizing: Reducing Risk, Cutting Cost and Saving Time in Preclinical Inhalable Formulation Development
of new drug approval applications submitted to regulatory authorities, pharmaceutical companies are continuing to pursue new delivery methods for their drug products. The inhalation and nasal products had combined sales exceeding US$22 billion in 2007 for treatment of asthma, COPD, allergic rhinitis, influenza, migraine and osteoporosis, and for use in general anaesthesia. 1 One common trend is...
متن کاملGuidelines for the use of systemic drugs in the treatment of skin diseases
Systemic drugs are used in the treatment of several skin diseases. In order to obtain best therapeutic results and prevent side effects, the patients should be carefully screened before and thoroughly evaluated during treatment. In this article guidelines for selection and follow up of patients receiving systemic drugs for their skin diseases are presented. These drugs include azathioprine, ant...
متن کاملRNA nanotechnology breakthrough for targeted release of RNA-based drugs using cell-based aptamers
Nucleic acids play different roles besides storing information and proteins coding. For example, single-stranded nucleic acids can fold into complicated structures with capability of molecular detection, catalyzing bioreactions and therapy. The development of RNA-based therapies has been rapidly progressed in the recent years. RNA aptamers are biomolecules with a size of 10 to 50 nm that can be...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Respiratory care
دوره 45 7 شماره
صفحات -
تاریخ انتشار 2000